2-(2-Imino-4-oxothiazolidin-5-yl)acetic acid

Catalog No. :
ACVDCJ534
CAS No. :
33176-41-9
Molecular Formula :
C5H6N2O3S
Molecular Weight :
174.18

IUPAC Name:2-(2-amino-4-oxo-4,5-dihydrothiazol-5-yl)acetic acid

2-(2-Imino-4-oxothiazolidin-5-yl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$56.00Login to see priceIn stockInquiry
250mg95%$75.00Login to see priceIn stockInquiry
1g95%$168.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-Imino-4-oxothiazolidin-5-yl)acetic acid
IUPAC Name2-(2-amino-4-oxo-4,5-dihydrothiazol-5-yl)acetic acid
Molecular FormulaC5H6N2O3S
Molecular Weight174.18
SMILESO=C(O)CC(SC(N1)=N)C1=O
InChI KeyIFUXBSJTQXUMSX-UHFFFAOYSA-N
Synonym2-(2-amino-4-oxo-1,3-thiazol-5-yl)acetic acid;(2-imino-4-oxo-1,3-thiazolidin-5-yl)acetic acid;5-thiazolidineacetic acid, 2-imino-4-oxo-;5-Thiazoleacetic acid,2-aMino-4,5-dihydro-4-oxo-;2-(2-amino-4-keto-thiazol-5-yl)acetic acid;2-(2-amino-4-oxo-1,3-thiazol-5-yl)ethanoic acid;2-(2-amino-4-oxo-5-thiazolyl)acetic acid;2-(2-amino-4-oxo-thiazol-5-yl)acetic acid
CAS No.33176-41-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACVDCJ534 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVDCJ534 route product structure diagram
    ACVDCJ53433176-41-9 In Stock
Inquiry

2. ACVDCJ534 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVDCJ534 route product structure diagram
    ACVDCJ53433176-41-9 In Stock
Inquiry

Comments (0)